Kim Kardashian West promotes morning sickness drug on Instagram despite previous FDA warning
Kim Kardashian West has stirred up controversy on Instagram, after posting an ad promoting the same anti-morning sickness drug which landed her in hot water with the FDA a few years ago.
The original ad was removed from Kardashian West's Twitter after the FDA sent the star a warning
The Keeping Up With the Kardashians star – who is not believed to pregnant – shared a somewhat bizarre image pitching the prescription medication, Diclegis, to her followers on Thursday (13 April). The post was complete with a caption laden with medical and legal information.
The most recent ad contains a Photoshopped smartphone which features Kardashian West's original sponsored selfie from 2015. The personality was pressured to remove the photo by the FDA after failing to disclose the side effects of the drug.
Unlike the previous iteration the latest picture is signposted as an ad from the outset, with the accompanying text being much less conversational and warning prospective customers of all the drug's risks.
The original ad led to the FDA issuing specific guidelines for celebrity endorsements, leaving some of the stars followers to question why she is promoting the medication once more.
The federal agency had previously lodged a complaint about the Diclegis' ads in 2013. The medication is FDA approved but earlier this year a study called into question its effectiveness.
Duchesnay, the Canadian pharmaceutical company behind the drug, said in a statement earlier in January: "We have complete confidence in the safety and efficacy of Diclectin and are very proud to provide it as a safe and effective treatment option for women suffering from nausea and vomiting of pregnancy."
Kardashian West's sister, Kendall Jenner, was plunged into controversy earlier this month after featuring in a Pepsi ad accused of mocking the Black Lives Matter movement. The spot was subsequently pulled by the brand.